These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis. Ghiggeri GM; Musante L; Candiano G; Bruschi M; Santucci L; Barbano G; Trivelli A; Rivabella L; Gusmano R; Perfumo F Pediatr Nephrol; 2007 Nov; 22(11):1953-6. PubMed ID: 17661091 [TBL] [Abstract][Full Text] [Related]
6. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Hari P; Bagga A; Jindal N; Srivastava RN Pediatr Nephrol; 2001 Nov; 16(11):901-5. PubMed ID: 11685598 [TBL] [Abstract][Full Text] [Related]
7. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543 [TBL] [Abstract][Full Text] [Related]
8. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Alexopoulos E; Stangou M; Papagianni A; Pantzaki A; Papadimitriou M Nephrol Dial Transplant; 2000 Sep; 15(9):1348-56. PubMed ID: 10978390 [TBL] [Abstract][Full Text] [Related]
9. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports. Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416 [TBL] [Abstract][Full Text] [Related]
10. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children. Hattori M; Chikamoto H; Akioka Y; Nakakura H; Ogino D; Matsunaga A; Fukazawa A; Miyakawa S; Khono M; Kawaguchi H; Ito K Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182 [TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Feld SM; Figueroa P; Savin V; Nast CC; Sharma R; Sharma M; Hirschberg R; Adler SG Am J Kidney Dis; 1998 Aug; 32(2):230-7. PubMed ID: 9708606 [TBL] [Abstract][Full Text] [Related]
12. Renal disease. II. The treatment of minimal change nephropathy and focal segmental glomerulosclerosis. Mason PD J R Coll Physicians Lond; 1997; 31(2):137-41. PubMed ID: 9131509 [No Abstract] [Full Text] [Related]
13. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis. Ginsburg DS; Dau P Clin Nephrol; 1997 Nov; 48(5):282-7. PubMed ID: 9403211 [TBL] [Abstract][Full Text] [Related]
14. A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis. Oliveira L; Wang D; McCormick BB Ther Apher Dial; 2007 Jun; 11(3):227-31. PubMed ID: 17498006 [TBL] [Abstract][Full Text] [Related]
15. Focal segmental glomerulosclerosis associated with acute cytomegalovirus infection in a renal transplant. Wynd E; Stewart A; Burke J Pediatr Transplant; 2019 Sep; 23(6):e13538. PubMed ID: 31271240 [TBL] [Abstract][Full Text] [Related]
16. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab]. Tatangelo P; Londrino F; Di Vasta G; Guido G; Centi A; Dominijanni S; Bernabei E; Caramiello MS; Di Franco D; Palumbo R G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786187 [TBL] [Abstract][Full Text] [Related]